Literature DB >> 11194734

Antibiotic resistance in Helicobacter pylori.

L C Mollison1, N Stingemore, R A Wake, D J Cullen, D B McGechie.   

Abstract

OBJECTIVE: To describe antibiotic resistance patterns in Helicobacter pylori.
DESIGN: Culture and antibiotic sensitivity testing of antral and gastric body biopsy samples from patients having gastroscopy. PARTICIPANTS: Consecutive consenting patients aged 18 years or more presenting for gastroscopy from 1 July 1998 to 30 June 1999.
SETTING: An open-access gastroscopy service at an urban university tertiary hospital. MAIN OUTCOME MEASURES: Number of H. pylori isolates showing resistance to antibiotics; correlates of such resistance with demographic and clinical information.
RESULTS: Of 1580 patients undergoing endoscopy, 434 agreed to participate in the study. 108 (24.9%) had positive cultures for H. pylori, and 88 of these isolates (81%) were available for further testing. Resistance to metronidazole and clarithromycin was detected in 36% and 11%, respectively. No resistance was found to tetracycline or amoxycillin. Metronidazole resistance was commoner in younger patients (P = 0.0004) and macrolide resistance was commoner in those born outside Australia or New Zealand (P = 0.03).
CONCLUSIONS: We found substantial resistance to metronidazole, and emerging clarithromycin resistance, but complete susceptibility to amoxycillin, tetracycline, gentamicin and cefaclor. These factors may influence the effectiveness of presently recommended eradication regimens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11194734     DOI: 10.5694/j.1326-5377.2000.tb139319.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

1.  One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy.

Authors:  Hwang-Huei Wang; Jen-Wei Chou; Kuan-Fu Liao; Zong-Yi Lin; Hsueh-Chou Lai; Chang-Hu Hsu; Chih-Bin Chen
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

2.  N-acetylcysteine, a novel treatment for Helicobacter pylori infection.

Authors:  Hien Quoc Huynh; Richard T L Couper; Cuong D Tran; Lynette Moore; Richard Kelso; Ross N Butler
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

3.  Epidemiology of Helicobacter pylori in Australia: a scoping review.

Authors:  Jillian Congedi; Craig Williams; Katherine L Baldock
Journal:  PeerJ       Date:  2022-05-31       Impact factor: 3.061

Review 4.  How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Authors:  Enzo Ierardi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

5.  Vitamin B6 is required for full motility and virulence in Helicobacter pylori.

Authors:  Alexandra Grubman; Alexandra Phillips; Marie Thibonnier; Maria Kaparakis-Liaskos; Chad Johnson; Jean-Michel Thiberge; Fiona J Radcliff; Chantal Ecobichon; Agnès Labigne; Hilde de Reuse; George L Mendz; Richard L Ferrero
Journal:  mBio       Date:  2010-08-17       Impact factor: 7.867

6.  A Newly Discovered Drug Resistance Gene rfaF In Helicobacter pylori.

Authors:  Jiansheng Lin; Xiaoyan Zhang; Yancheng Wen; Hao Chen; Feifei She
Journal:  Infect Drug Resist       Date:  2019-11-12       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.